NCT02994446View on ClinicalTrials.gov

Saline-Enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 21, 2021

Study Completion Date

October 4, 2021

Conditions
Tachycardia, Ventricular
Interventions
DEVICE

Saline-Enhanced Radiofrequency Catheter and Ablation System

Ablation of ventricular tachycardia with a saline-enhanced radiofrequency ablation catheter

Trial Locations (3)

L3Y-2P6

Southlake Regional Health Centre, Newmarket

H1T 1C8

Montreal Heart Institute - Institut de Cardiologie de Montréal, Montreal

Unknown

Quebec Heart and Lung Institute - Institut universitaire de cardiologie et de pneumologie de Québec, Québec

All Listed Sponsors
lead

Thermedical, Inc.

INDUSTRY

NCT02994446 - Saline-Enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia | Biotech Hunter | Biotech Hunter